Skip to main content
FinSpry Logo
FinSpry
VVOS logo
VVOS
(NASDAQ)
Vivos Therapeutics, Inc.
$0.57-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Vivos Therapeutics (VVOS) Stock Price & Financial Analysis

Vivos Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.56 - $0.62
52-Week High$7.95
52-Week Low$0.55
Open$0.58
Volume279.04K
Average Volume (3M)2.53M
Market Cap5.93M
Shares Outstanding9.29M
Price to Sales (P/S)0.33
Price to Book (P/B)-3.98
EV/EBITDA-0.84
Revenue (TTM)18.25M
Net Income (TTM)-24.32M
Free Cash Flow (TTM)-17.58M
EPS (TTM)$-2.33
Profit Margin-133.26%
Operating Margin-122.53%
50-Day MA$0.86
200-Day MA$1.97
52-Week Change-72.36%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Vivos Therapeutics

What is the current stock price for VVOS?

As of the latest trading session, VVOS stock trades at $0.57. The 52-week range is $0.55–$7.95, with a day range of $0.56–$0.62.

What is the P/E ratio for VVOS?

The P/E ratio (Price-to-Earnings) for VVOS is shown in the Key Statistics section. This valuation metric helps compare Vivos Therapeutics, Inc. to industry peers.

Does VVOS pay dividends?

Vivos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VVOS?

Based on 2 analysts, the consensus for VVOS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VVOS?

Vivos Therapeutics's market capitalization is $5.3M, classifying it as a micro-cap company. Vivos Therapeutics operates in the Healthcare sector within the Medical Devices industry.